Your account is not claimed yet. You can sign up with ORCID to claim your account.

Fabian Dominik Mairinger (Fabian D Mairinger, Fabian Mairinger)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Venues

International journal of molecular sciences

Cancer management and research

Journal of oncology

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Sabrina Borchert, Alexander Mathilakathu, Alina Nath, Michael Wessolly, Elena Mairinger, Daniel Kreidt, Julia Steinborn, Robert F H Walter, Daniel C Christoph, Jens Kollmeier, Jeremias Wohlschlaeger, Thomas Mairinger, Luka Brcic, Fabian Dominik Mairinger
Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning Model. International journal of molecular sciences 24 (15) (2023)
Susann Stephan-Falkenau, Anna Streubel, Thomas Mairinger, Torsten-Gerriet Blum, Jens Kollmeier, Fabian Dominik Mairinger, Torsten T Bauer, Joachim Pfannschmidt, Manuel Hollmann, Michael Wessolly
Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies. International journal of molecular sciences 24 (13) (2023)
Markus Leo, Linda-Isabell Schmitt, Fabian Dominik Mairinger, Andreas Roos, Christina Hansmann, Stefanie Hezel, Jelena Skuljec, Refik Pul, Ulrike Schara-Schmidt, Christoph Kleinschnitz, Tim Hagenacker
Analysis of Free Circulating Messenger Ribonucleic Acids in Serum Samples from Late-Onset Spinal Muscular Atrophy Patients Using nCounter NanoString Technology. Cells 12 (19) (2023)
Thomas Hager, Sabrina Borchert, Michael Wessolly, Alexander Mathilakathu, Elena Mairinger, Jens Kollmeier, Thomas Mairinger, Balazs Hegedüs, Kristina Greimelmaier, Jeremias Wohlschlaeger, Ken Herrmann, Fabian Dominik Mairinger
One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy. International journal of molecular sciences 24 (7) (2023)
Sabrina Borchert, Pia-Maria Suckrau, Robert F H Walter, Michael Wessolly, Elena Mairinger, Julia Steinborn, Balazs Hegedüs, Thomas Hager, Thomas Herold, Wilfried E E Eberhardt, Jeremias Wohlschlaeger, Clemens Aigner, Agnes Bankfalvi, Kurt Werner Schmid, Fabian Dominik Mairinger
Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma. Scientific reports 10 (1) (2020)
Michael Wessolly, Susann Stephan-Falkenau, Anna Streubel, Robert Werner, Sabrina Borchert, Sergej Griff, Elena Mairinger, Robert F H Walter, Torsten Bauer, Wilfried E E Eberhardt, Torsten Gerriet Blum, Kurt Werner Schmid, Jens Kollmeier, Thomas Mairinger, Fabian Dominik Mairinger
A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient's Suitability for Immune Checkpoint Inhibition. Cancer management and research 12 (2020)
Sabrina Borchert, Pia-Maria Suckrau, Michael Wessolly, Elena Mairinger, Balazs Hegedus, Thomas Hager, Thomas Herold, Wildfried E E Eberhardt, Jeremias Wohlschlaeger, Clemens Aigner, Agnes Bankfalvi, Kurt Werner Schmid, Robert F H Walter, Fabian Dominik Mairinger
Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based Chemotherapy. Journal of oncology 2019 (2019)
Fabian Dominik Mairinger, Agnes Bankfalvi, Kurt Werner Schmid, Elena Mairinger, Pawel Mach, Robert F H Walter, Sabrina Borchert, Sabine Kasimir-Bauer, Rainer Kimmig, Paul Buderath
Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response. Cancer management and research 11 (2019)
Robert F H Walter, Robert Werner, Michael Wessolly, Elena Mairinger, Sabrina Borchert, Jan Schmeller, Jens Kollmeier, Thomas Mairinger, Thomas Hager, Agnes Bankfalvi, Daniel C Christoph, Wilfried E E Eberhardt, Till Plönes, Clemens Aigner, Kurt W Schmid, Jeremias Wohlschlaeger, Fabian Dominik Mairinger
Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53. Journal of oncology 2018 (2018)

Fabian Dominik Mairinger.css-eqlu8i{font-size:small;padding-left:4px;} (Fabian D Mairinger, Fabian Mairinger)

Publication Activity (10 Years)

Top Topics

Top Venues

Fabian Dominik Mairinger (Fabian D Mairinger, Fabian Mairinger)